Sophie Girerd

571 total citations
19 papers, 339 citations indexed

About

Sophie Girerd is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sophie Girerd has authored 19 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Transplantation and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sophie Girerd's work include Renal Transplantation Outcomes and Treatments (7 papers), Hormonal Regulation and Hypertension (5 papers) and Liver Disease and Transplantation (3 papers). Sophie Girerd is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Hormonal Regulation and Hypertension (5 papers) and Liver Disease and Transplantation (3 papers). Sophie Girerd collaborates with scholars based in France, United Kingdom and Sweden. Sophie Girerd's co-authors include Frédéric Jaisser, Jonatan Barrera‐Chimal, Nicolas Girerd, Luc Frimat, Toshifumi Nakamura, Zohra Lamiral, Alan G. Jardine, Hallvard Holdaas, Roland E. Schmieder and Bengt Fellström and has published in prestigious journals such as Kidney International, Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

Sophie Girerd

19 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Girerd France 9 166 95 92 77 63 19 339
Periklis Dousdampanis Greece 12 78 0.5× 63 0.7× 90 1.0× 28 0.4× 38 0.6× 35 378
Jacinthe Boulet Canada 9 52 0.3× 87 0.9× 66 0.7× 114 1.5× 45 0.7× 17 348
Jacentha Buggs United States 14 87 0.5× 46 0.5× 132 1.4× 66 0.9× 88 1.4× 42 388
Alberto Casaretto United States 7 122 0.7× 26 0.3× 107 1.2× 55 0.7× 80 1.3× 8 432
J. Chahin Spain 9 94 0.6× 34 0.4× 60 0.7× 62 0.8× 48 0.8× 14 445
Yume Nagaoka Japan 13 248 1.5× 47 0.5× 65 0.7× 87 1.1× 51 0.8× 39 569
Chieh‐Li Yen Taiwan 12 86 0.5× 45 0.5× 97 1.1× 43 0.6× 30 0.5× 44 383
Sheila Bermejo Spain 13 81 0.5× 44 0.5× 83 0.9× 41 0.5× 34 0.5× 30 368
M Fusaroli Italy 9 75 0.5× 78 0.8× 61 0.7× 189 2.5× 64 1.0× 32 554
J.B. Cabezuelo Spain 10 43 0.3× 67 0.7× 304 3.3× 26 0.3× 46 0.7× 28 487

Countries citing papers authored by Sophie Girerd

Since Specialization
Citations

This map shows the geographic impact of Sophie Girerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Girerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Girerd more than expected).

Fields of papers citing papers by Sophie Girerd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Girerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Girerd. The network helps show where Sophie Girerd may publish in the future.

Co-authorship network of co-authors of Sophie Girerd

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Girerd. A scholar is included among the top collaborators of Sophie Girerd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Girerd. Sophie Girerd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Girerd, Sophie, et al.. (2023). Antagonistes du récepteur minéralocorticoïde. médecine/sciences. 39(4). 335–343. 1 indexed citations
2.
Ayav, Carole, Luc Frimat, Cécile Couchoud, et al.. (2023). Evolution of HLA‐sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study. Clinical Transplantation. 38(1). e15160–e15160. 2 indexed citations
3.
Girerd, Sophie, et al.. (2023). Potassium canrenoate in brain-dead organ donors: a randomised controlled clinical trial protocol (CANREO-PMO). BMJ Open. 13(10). e073831–e073831. 1 indexed citations
4.
Girerd, Nicolas, Anna Kearney‐Schwartz, Kévin Duarte, et al.. (2023). Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wave Velocity, and Cardiovascular Morbidity and Mortality in 44 Patients 2 Years After Kidney Transplantation. Annals of Transplantation. 28. e938137–e938137. 1 indexed citations
5.
Girerd, Nicolas, Erwan Bozec, Zohra Lamiral, et al.. (2023). Factors associated with changes in echocardiographic parameters following kidney transplantation. Clinical Research in Cardiology. 113(3). 412–424. 3 indexed citations
6.
Girerd, Nicolas, Anna Kearney‐Schwartz, Patrick Rossignol, et al.. (2022). Association between Long-Term Change in Arterial Stiffness and Cardiovascular Outcomes in Kidney Transplant Recipients: Insights from the TRANSARTE Study. Journal of Clinical Medicine. 11(5). 1410–1410. 5 indexed citations
7.
Nakamura, Toshifumi, Sophie Girerd, Frédéric Jaisser, & Jonatan Barrera‐Chimal. (2022). Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease. Kidney International Supplements. 12(1). 12–18. 31 indexed citations
8.
Girerd, Sophie, Nicolas Girerd, Winfried März, et al.. (2021). Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial. Clinical Research in Cardiology. 111(6). 614–626. 12 indexed citations
9.
Kobayashi, Masatake, Olivier Huttin, Erwan Bozec, et al.. (2020). Cardiovascular Comorbidities Are the Main Predictors of Cardiac Reverse Remodeling following Kidney Transplantation. Cardiology. 145(2). 71–76. 7 indexed citations
10.
Barrera‐Chimal, Jonatan, Sophie Girerd, & Frédéric Jaisser. (2019). Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis. Kidney International. 96(2). 302–319. 170 indexed citations
12.
Girerd, Sophie, Nicolas Girerd, Luc Frimat, et al.. (2019). Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial. Clinical Kidney Journal. 13(1). 116–122. 28 indexed citations
13.
Girerd, Nicolas, Stefano Coiro, Zohra Lamiral, et al.. (2018). Evaluation of Subclinical Fluid Overload Using Lung Ultrasound and Estimated Plasma Volume in the Postoperative Period Following Kidney Transplantation. Transplantation Proceedings. 50(5). 1336–1341. 10 indexed citations
14.
Girerd, Sophie, Luc Frimat, Yannick Le Meur, et al.. (2018). EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial. Trials. 19(1). 595–595. 11 indexed citations
15.
16.
Girerd, Sophie & Frédéric Jaisser. (2018). Mineralocorticoid receptor antagonists in kidney transplantation: time to consider?. Nephrology Dialysis Transplantation. 33(12). 2080–2091. 10 indexed citations
17.
Cognard, Noëlle, Dany Anglicheau, Philippe Gatault, et al.. (2017). Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort. Transplantation. 102(5). 860–867. 14 indexed citations
18.
Martin, Laurent, et al.. (2016). Glomérulonéphrite aiguë post-infectieuse à Streptococcus equi subsp. zooepidemicus : premier cas décrit en France. Néphrologie & Thérapeutique. 13(1). 37–41. 2 indexed citations
19.
Girerd, Sophie, et al.. (2013). Long-term follow-up of corticosteroid refractory acute GVHD treated with an Inolimomab-based algorithm: a single center experience. Bone Marrow Transplantation. 48(9). 1243–1248. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026